Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.
-
Zhang S, Li M, Liu M, Patten ND, Labaf M, Jeong J, Sun H, Lourie J, Zou K, Patalano S, Mulhearn MJ, Macoska JA, Gao S, Andreotti R, Pennuto M, Han D, Balk SP, Cai C. Minimal-length CAG repeats in AR define a hyperactive AR-LSD1 axis driving metabolic reprogramming in prostate cancer. Proc Natl Acad Sci U S A. 2026 Sep 15; 123(37):e2534152123.
-
Garg A, Mannheimer JD, Gardner H, London CA, Hendricks WPD, Wang G, Day K, Sakthikumar S, Warrier M, Mazcko C, Beck JA, LeBlanc AK. Integrated Multiomic Profiling Enhances Risk Stratification and Prognostication in Canine Osteosarcoma. Clin Cancer Res. 2026 Aug 14; 32(16):3668-3682.
-
Dong Y, Liu M, Gao R, Li M, Zhai J, Cai C, Gao S. Identification of targets of clinical FOXA1 mutants involved in EMT and immune suppression in prostate cancer. Commun Biol. 2026 Jun 23; 9(1).
-
Onoyama I, Hardy WR, Takeishi S, Zhu LJ, Tan Y, Hutchinson L, Ou J, Ma L, Virbasius CM, Yasunaga M, Nakayama KI, Shaffer SA, Green MR. Oncogenic BRAF and KRAS Promote Global DNA Hypomethylation Through a Directed Pathway That Upregulates TET3. Cancer Sci. 2026 Sep; 117(9):2397-2412.
-
Jamroze A, Liu X, Hou S, Jess Li W, Yu H, Tracz A, Jacobi J, Li Q, Nastiuk K, Chen X, Huang J, Lin K, Liu M, Cai C, Lu Y, Puzanov I, Kirk JS, Chatta G, Tang DG. Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer. Signal Transduct Target Ther. 2026 May 01; 11(1).
-
Steiner D, Sultan L, Sullivan T, Liu H, Xiao X, LeClerc A, Melvin S, Alekseyev YO, Liu G, Mazzilli SA, Zhang J, Suzuki K, Rieger-Christ K, Burks EJ, Beane J, Lenburg ME. Vascular invasion-associated gene expression is detectable in pre-surgical biopsies of stage I lung adenocarcinoma. Nat Commun. 2026 Mar 24; 17(1).
-
Rao K, Rao Z, Huang A, Heston S, Wang M, Yildiz-Altay Ü, Qutab F, Kwong DA, Gardner HL, Richmond JM, London CA. Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCL. Sci Rep. 2026 Mar 17; 16(1).
-
Qu W, Jia J, Zhang N, Wang R, Liu Y, Zhang S, Gao H, Tao Y, Jia L, Liu Y, Zhao J. Oncogenic role of PHF23 in gastric cancer progression. Funct Integr Genomics. 2026 Mar 04; 26(1).
-
Tang X, Liu L, Gao M, Duan P, Li S, Yuan Z, Xia Q, Xi L, Tan Y. Single-cell transcriptomics identifies fibroblast associated immune heterogeneity and prognostic signatures in bladder cancer. Sci Rep. 2026 Feb 03; 16(1):7151.
-
Nisco A, Tolomeo M, Sposato A, Paleni D, Scalise M, Barile M. Alteration of Flavin Homeostasis in Uterine Cancer. Anticancer Res. 2026 Feb; 46(2):681-688.